| Name: | Apixaban Amino Acid Impurity |
| Catalogue No. | VL3170013 |
| CAS No. | 2206825-87-6 |
| Molecular Formula | C25H27N5O5 |
| Molecular Weight | 477.52 g/mol |
| Status | In-Stock |
| IUPAC Name | 5-((4-(3-carbamoyl-1-(4-methoxyphenyl)-7-oxo-1,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridin-6-yl)phenyl)amino)pentanoic acid |
| Description | Apixaban Amino Acid Impurity (CAS No: 2206825-87-6) or 5-((4-(3-carbamoyl-1-(4-methoxyphenyl)-7-oxo-1,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridin-6-yl)phenyl)amino)pentanoic acid, it produces its antithrombotic effect by inhibiting free and clot-bound factor Xa and is used as Treatment And Prevention of Thromboembolic Disease. |
| References | Budovich, Aliaksandr, et al. “Role of Apixaban (Eliquis) in the Treatment and Prevention of Thromboembolic Disease.” Pharmacy and Therapeutics, vol. 38, no. 4, 1 Apr. 2013, pp. 206–231, www.ncbi.nlm.nih.gov/pmc/articles/PMC3684191/#b5-ptj3804206. |
